Table 2.

Demographic and clinical data for Chinese patients with active or stable SLE

	Active SLE	Stable SLE
N	21	25
Age, yr	33.5 ± 14.2**	36.2 ± 12.3
Female, n (%)	19 (90.5)**	23 (92.0)
Male, n (%)	2 (9.5)**	2 (8.0)
ANA (+), n (%)	21 (100)	25 (100)
dsDNA (+), n (%)	14(67)*	6(24)
C3, g/L	0.64 ± 0.41*	0.94 ± 0.35
C4, g/L	0.13 ± 0.11**	0.20 ± 0.13
SLEDAI score	13.9 ± 3.2*	5.4 ± 2.1

Values shown are mean ± SD unless otherwise noted

ANA, anti-nuclear antibody; C, complement; SLEDAI, systemic lupus erythematosus disease activity index

*p < 0.05 compared to stable SLE group

**p > 0.05 compared to stable SLE group